Get the latest industry news first when you subscribe to our daily newsletter.
A study published in peer-reviewed American Journal of Health-System Pharmacy last month found that machine learning and advanced analytics technology can successfully identify instances of drug diversion – a term for when drugs are stolen from healthcare facilities – 160 days faster than traditional, non machine methods. AI can do so even with high volumes of data, unlike its human counterpart who have kept track of the missing drugs until now.
The study came from Atlanta, Georgia-based Invistics, a software company with technology for analyzing and tracking inventory in healthcare systems.
The retrospective study looked at drug diversion at 10 acute-care inpatient hospitals that are part of four health systems in total. The data analyzed included 27.9 million medication movement transactions from nurses, pharmacy, and anesthesia clinicians, spanning over the course of 8 to 24 months.
Thrown into the mix were 22 known drug diversion cases. The study aimed to see if machine learning and analytics technology could not only successfully identify those cases from the 27.9 million, but if machine learning and analytics technology could do so faster than the current standard of detection that originally found these 22 diversions.
Historical methods of diversion detection include looking at monthly usage reports or daily discrepancy reports. However, these standard methods of detection prove problematic on a few fronts. For one, people can hide diversion. And two, any diversion that is detected often is not flagged immediately since the data is reviewed weeks or months after it occurs. Further, hospitals historically rely on clinicians reporting impaired coworkers’ behavior to drive investigation of possible diversion.
The study noted that not only did the machine learning and advanced analytics technology flag the 22 cases of drug diversion, but it did so 160 days before standard methods, on average. Further, the machine learning method technology had a high accuracy rate — 96.3%.
“The findings prove that advances in machine learning and analytics are a real game changer — and can improve the detection of drug diversion in hospitals and other healthcare settings,” says Tom Knight, CEO of Invistics, in a news release. “This is really important, considering the huge financial, clinical, and emotional burden that medication theft imposes on healthcare systems, patients, and families.”
Aside from Invistics, other institutions involved in the study were: Piedmont Athens Regional Medical Center, Scripps Health, Piedmont Healthcare, and EnvisionChange.
Imagine what replacing wellness solutions with digital therapeutics could do…
Professor Colin Espie, PhD, Co-Founder and Chief Scientist at Big Health
The rising cost of employer-sponsored healthcare makes it difficult for American businesses to compete globally. That doesn’t have to be the reality. Learn how one company changed its trajectory.
Tom Gentile, CEO of Spirit AeroSystems & Richard Gephardt, Co-founder of SolidaritUS Health
TSX Venture Exchange has a strong history of helping early stage health and life sciences companies raise patient capital for research and development purposes.
Daniel Lubienietzky, Toronto Stock Exchange
MedCity INVEST PharmaTech, a virtual event to be held July 26, 2022 is a virtual executive summit where established biopharma companies gather with health tech and digital health innovators to transform the industry. Reserve your spot now.>>
GOT NEWS? SEND US A TIP
Get the latest industry news first when you subscribe to our newsletter.
A webinar, sponsored by Surescripts on April 28, will include: Surescripts CEO Tom Skelton, Epic CEO Judy Faulkner, Healthcare Leadership Council President Mary Grealy, and UC San Francisco Assistant Professor of Medicine A. Jay Holmgren. Register today!
© 2022 Breaking Media, Inc. All rights reserved. Registration or use of this site constitutes acceptance of our Terms of Service and Privacy Policy.
Privacy Center | Do not sell my information